For example, AKT inhibitors reduce cell proliferation and inflammatory responses in psoriatic skin.[49,50] IL1B expression levels are significantly elevated in patients with psoriasis and are strongly correlated with disease severity, which could indicate that AKT1 is a potential target for psoriasis treatment. The gene discussed is IL1B; the disease is psoriasis.